Profil
John Paul Gabriel is currently Chief Technical Operations Officer at Silence Therapeutics Plc since 2022.
Formerly, Mr. Gabriel was Senior Vice President-Technical Operations at Ocugen, Inc. from 2021 to 2022 and Vice President-Biologics & mRNA Manufacturing at Ultragenyx Pharmaceutical, Inc. Education includes an undergraduate degree from the University of Guelph.
Aktiva positioner av J.P. Gabriel
| Företag | Position | Start |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Teknisk/Vetenskaplig/F&U Direktör | 2022-11-01 |
Tidigare kända positioner av J.P. Gabriel
| Företag | Position | Slut |
|---|---|---|
| OCUGEN, INC. | Företagsledare/Principal | 2022-09-01 |
| ULTRAGENYX PHARMACEUTICAL INC. | Företagsledare/Principal | - |
J.P. Gabriels utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Ultragenyx Pharmaceutical, Inc.
Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Silence Therapeutics Plc
Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
University of Guelph
University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ocugen, Inc.
Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products | Health Technology |
















